Skip to main content
Elsevier

Journals in Medicine

The Medicine portfolio strives to advance medicine by delivering superior evidence-based education, reference information and decision support tools to clinicians, trainees, and students. Specialties covered include Anesthesiology, Internal Medicine, Surgery, Radiology & Imaging, Pathology, Orthopedics, Ophthalmology, Infectious Disease, Allergy & Immunology, Pediatrics, Obstetrics & Gynecology, Hematology & Oncology, Plastic Surgery, and many more. The Medicine portfolio includes world-renowned titles such as Gray's Anatomy and Netter Atlas of Human Anatomy, Braunwald's Heart Disease, Goldman-Cecil Medicine, Osborn's Brain, Dermatology (Bolognia), Diagnostic Ultrasound (Rumack), The Harriet Lane Handbook, Fanaroff and Martin's Neonatal-Perinatal Medicine, Ferri's Clinical Advisor, Conn's Current Therapy, and more.

  • Clinical Breast Cancer

    • ISSN: 1526-8209
    Clinical Breast Cancer is a peer-reviewed journal dedicated to publishing original articles on all aspects of clinical and translational research related to breast cancer. The journal focuses on the latest scientific advancements in the detection, diagnosis, prevention, and treatment of breast cancer.Specific areas of interest include clinical research reports from various therapeutic modalities, cancer genetics, drug sensitivity and resistance, novel imaging, tumor genomics, biomarkers, and chemoprevention strategies.Manuscrip... reporting non-clinical or translational studies must include functional experiments that directly support the study’s conclusions. Purely correlative studies without functional validation or mechanistic insights will not be considered. All research should demonstrate a clear and direct relevance to the clinical setting, highlighting potential implications for patient care or therapeutic development.
    Subscriptions

  • Clinical Lung Cancer

    • ISSN: 1525-7304
    Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
    Subscriptions

  • HPB

    • ISSN: 1365-182X
    To visit the HPB journal website click here: http://www.hpbonline... is an international forum for clinical, scientific and educational communication.Twelve issues a year bring the reader leading articles, expert reviews, original articles, images, editorials, and reader correspondence encompassing all aspects of benign and malignant hepatobiliary disease and its management. HPB features relevant aspects of clinical and translational research and practice.Specific areas of interest include HPB diseases encountered globally by clinical practitioners in this specialist field of gastrointestinal surgery. The journal addresses the challenges faced in the management of cancer involving the liver, biliary system and pancreas. While surgical oncology represents a large part of HPB practice, submission of manuscripts relating to liver and pancreas transplantation, the treatment of benign conditions such as acute and chronic pancreatitis, and those relating to hepatobiliary infection and inflammation are also welcomed. There will be a focus on developing a multidisciplinary approach to diagnosis and treatment with endoscopic and laparoscopic approaches, radiological interventions and surgical techniques being strongly represented. HPB welcomes submission of manuscripts in all these areas and in scientific focused research that has clear clinical relevance to HPB surgical practice.HPB aims to help its readers - surgeons, physicians, radiologists and basic scientists - to develop their knowledge and practice. HPB will be of interest to specialists involved in the management of hepatobiliary and pancreatic disease however will also inform those working in related fields.HPB is owned by the International Hepato-Pancreato-Bil... Association (IHPBA) and is also the official Journal of the American Hepato-Pancreato-Bil... Association (AHPBA), the Asian-Pacific Hepato Pancreatic Biliary Association (A-PHPBA) and the European-African Hepato-Pancreatic Biliary Association (E-AHPBA).
    Subscriptions

  • Advanced Drug Delivery Reviews

    • ISSN: 0169-409X
    The aim of the Journal is to provide a forum for the critical analysis of advanced drug and gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope, covering the key issues for effective drug and gene delivery, from administration to site-specific delivery.In general, the Journal publishes review articles in a Theme Issue format. Each Theme Issue provides a comprehensive and critical examination of current and emerging research on the design and development of advanced drug and gene delivery systems and their application to experimental and clinical therapeutics. The goal is to illustrate the pivotal role of a multidisciplinary approach to modern drug delivery, encompassing the application of sound biological and physicochemical principles to the engineering of drug delivery systems to meet the therapeutic need at hand. Importantly the Editorial Team of ADDR asks that the authors effectively window the extensive volume of literature, pick the important contributions and explain their importance, produce a forward looking identification of the challenges facing the field and produce a Conclusions section with expert recommendations to address the issues.Articles review the current status of a specific topic, giving equal emphasis to the identification of major conceptual and technological challenges to successful drug and gene delivery, to an evaluation of triumphs as well as shortcomings in current conceptual and technical approaches, and to a discussion of their possible solution.Theme issues are commissioned by one of the Executive Editors or the Editor-in-Chief. The Journal does not publish stand alone manuscripts. If you wish to submit a theme issue topic for consideration, please contact one of the editors.
    Subscriptions

  • Annals of the Rheumatic Diseases

    • ISSN: 0003-4967
    ARD is an international peer reviewed journal committed to promoting the highest standards of scientific exchange and education. It is the leading rheumatology journal publishing a combination of high-quality scientific papers, including original research, reviews, recommendations, viewpoints, and more. Clinical, basic and translational science across the inflammatory and non-inflammatory musculoskeletal conditions are part and parcel of this spectrum.
    Subscriptions

  • Preventive Medicine

    • ISSN: 0091-7435
    Founded in 1972 by Ernst Wynder, Preventive Medicine is an international scholarly journal that publishes original articles on the science, research, and practice of disease prevention, health promotion, and public health policymaking with a social determinants of health lens. Preventive Medicine aims to reward innovation. It will favor insightful observational studies, thoughtful explorations focusing on studies that use recent health data (within the last five years), unsuspected new angles for existing hypotheses, robust randomized controlled trials, and impartial systematic reviews. Preventive Medicine's ultimate goal is to publish research that will have an impact on the work of practitioners of disease prevention and health promotion, as well as public health and related disciplines.Preventi... Medicine is the companion title to the open access journal Preventive Medicine Reports, which publishes articles that form the building blocks of research in disease prevention and health promotion.
    Subscriptions

  • Annals of Vascular Surgery

    • ISSN: 0890-5096
    Annals of Vascular Surgery is the official publication for: • Brazilian Society of Angiology and Vascular Surgery• Chilean Society for Vascular and Endovascular Surgery• Chinese Society for Vascular Surgery• Florida Vascular Society• French Society for Vascular and Endovascular Surgery• Southern California Vascular Surgical Society• Vascular & Endovascular Surgery Society, USA• Vascular Surgeons of Spanish Language• Georgia Vascular SocietyAnnals of Vascular Surgery is published monthly (12 times per year). The journal invites original manuscripts reporting clinical and experimental work in vascular surgery, endovascular therapy, and vascular medicine. Articles may be submitted for the following sections:• Clinical Research• Basic Science Research• General Reviews / Meta-analysis• Basic Data Underlying Clinical Decision-making in Vascular Surgery• Historical Notes• CorrespondenceAnnals of Vascular Surgery no longer accepts Case Reports or Technical Notes. Authors are encouraged to submit these article types to Annals of Vascular Surgery: Brief Reports and Innovations.
    Subscriptions

  • Clinical Lymphoma, Myeloma & Leukemia

    • ISSN: 2152-2650
    Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
    Subscriptions

  • Smart Health

    • ISSN: 2352-6483
    This journal focuses on research topics pertaining to devices, sensing, computing and communication technologies, software/hardware modeling and system architectures towards Personalized, Pervasive, Participatory, Predictive, Preventive, Programmable and Perpetual (P7) Healthcare. This will be an interdisciplinary journal which would publish high-quality papers from researchers of various disciplines including medicine, computer science and engineering and bio and electrical engineering. Papers covering all aspects of P7 Healthcare including innovative technology, clinical studies of efficacy of existing technology, and analytical studies are in this journal.P7 Healthcare Models:E-healthcareM... TelemedicineCybermed... HealthcareP7 Platforms and Technologies:Home Health PlatformsCell-phone based monitoring systemsRemote/ Non-invasive BiomonitoringWireles... MedicineWearable health systemBody area networks (BANs)/Body Sensor Networks (BSNs)Nano medicineSmart medical DevicesP7 MethodsNon-invasive physiological monitoringReliable BiosensingHCI , Intuitive Interfaces for Children and the ElderlyPrivacy/Secur... Control ProtocolsWireless communicationP7 IT/Software-Hardware... Methods for ensuring safety, security of medical devicesInteroperable SecurityModel Based EngineeringMetrics, Performance Analysis methods and toolsPowering, Energy Management/Scavengin... SustainabilityModeli... techniques: cyber-physical, hybrid modelsSystem Software, Middelware, OS, NetworkingMedical device control system design, verification of control algorithmsP7 Patient Care Outcomes:Health Data PrivacyImproving Access and QualityCost-effectiv... Medical ErrorsP7 Applications:Assiste... LivingDisaster PreparednessEntertai... Games for Improving HealthDiabetes CareObesity ManagementDrug Use PreventionSports and Leisure
    Subscriptions

  • Cytotherapy

    • ISSN: 1465-3249
    Cytotherapy, the official journal of the International Society for Cell & Gene Therapy (ISCT), publishes novel and innovative results from high quality scientific and clinical studies in the fields of cell, gene, and extracellular vesicle therapy.Cytotherapy considers manuscripts exploring the following topics:Development and/or characterization of novel gene therapies and cell and/or EV-based therapeutics.Design of novel therapeutic approaches employing cell/EV/gene products.Scientific mechanisms of action of cell/EV/gene therapies in relevant cell-based and pre-clinical models.Scientific mechanisms of action of toxicities attributable to cell/EV/gene therapiesIdentificat... of novel biomarkers that predict the potency of cell/EV/gene therapies and/or stratify patients based on response rates.Early and late phase clinical studies evaluating the safety and efficacy of cell/EV/gene therapies.Important advances in cell/EV/gene-based product manufacturing and validation.Global/re... regulatory practices that impact the authorized use and/or regulatory approval of cell/EV and gene therapies.Cytotherap... does not publish manuscripts on the following topics:Case studies unless they are of unusual significance to the field.Basic/translat... studies exploring the role of lncRNAs, circRNAs, and miRNAs in disease pathophysiology.Fund... scientific studies of normal or pathological processesStudies describing signaling pathways implicated in cancer.
    Subscriptions

Related subjects